Provider review
TrimRx review
By The Dose Brief Desk · Updated
Official landing pages show different GLP-1 offers. Compare the exact plan, renewal price and cancellation conditions before using a headline number.
Not rated. This review examines published program information; it is not a firsthand treatment review.
At a glance
- Semaglutide
- $179 home offer; $174 on offer-v5; terms differ
- Tirzepatide
- $259 home offer; $279 on offer-v5; terms differ
- Availability
- State and prescribed-product eligibility require confirmation.
- Treatment formats
- Compounded GLP-1 programs; verify the selected prescription and formulation.
Public offers conflict; obtain the total commitment and renewal terms for the page you use.
Why TrimRx has more than one price
TrimRx’s home offer advertises GLP-1 treatment starting at $179 and GLP-1/GIP treatment at $259. Its separate offer-v5 page shows $174 for semaglutide and $279 for tirzepatide. Another price-lock page starts at $149. These are different advertised offers, not interchangeable estimates of one monthly bill.
Compare the whole offer
The offer pages describe bundles of medicine, consultation, follow-up and delivery. Before enrolling, ask which medication, supply length and dose are covered, the amount charged immediately, and the amount due at renewal. Save the terms for the offer you actually select, particularly if a discount depends on a longer commitment.
A guarantee needs its conditions
TrimRx promotes a three-month results guarantee in its own comparison article. That marketing description does not establish an unconditional refund. The operative eligibility requirements, deadlines and exclusions need to be read together with the cancellation terms before money is committed.
Questions worth resolving first
The public evidence reviewed did not establish a named dispensing pharmacy or prescribing organization for the selected plan, and the terms page did not fully render in this check. That is an evidence limit, not proof that these details are absent. Ask for them directly and clarify what happens if a clinician declines treatment or changes your prescription.
What stands out
- Several official offers can be compared
- Offers describe bundled follow-up and delivery
What to check
- Conflicting prices need plan-specific reconciliation
- Operative refund conditions remain unresolved
Sources and review scope
Public information checked in October 2026. Prices and eligibility can change. We have not enrolled in treatment, independently tested medications or verified the licenses of the clinicians and pharmacies involved in an individual prescription. Compounded medications are not FDA-approved; studies of approved brands do not establish that a compounded product has the same safety or effectiveness.